The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kasatkin D.S.

Poliklinika #5, Iaroslavl'

Authors:

Kasatkin D.S.

More about the authors

Read: 792 times

To cite this article:

Kasatkin DS. . S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(11):66‑69. (In Russ.)

Recommended articles:
Asthenia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):5-10
Neuroprotective therapy of glaucoma. Russian Annals of Ophthalmology. 2025;(1):83-90
Contemporary aspe­cts of brain protection in aortic arch surgery. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):164-173

References:

  1. Gusev E.I., Skvortsova V.I. Ishemiya golovnogo mozga. M: Meditsina 2001; 328.
  2. Zhivolupov S.A. Travmaticheskie porazheniya nervnykh stvolov konechnostei i spletenii (klinicheskie eksperimental'nye i morfologicheskie issledovaniya): Avtoref. dis. … d-ra med. nauk. St-Peterburg: VMedA 2000; 45-65.
  3. Suslina Z.A., Tanashyan M.M., Ionova V.G. i dr. Kavinton v lechenii bol'nykh s ishemicheskimi narusheniyami mozgovogo krovoobrashcheniya: novye aspekty deistviya. Rus med zhurn 2002; 10: 25: 1170-1174.
  4. Bereczki D., Fekete I. Vinpocetine for acute ischaemic stroke. Stroke 2008; 39: 2404-2405.
  5. Chan P.H. Oxygen radicals in focal cerebral ischemia. BrainPathol 1994; 4: 59-65.
  6. Chen R., Cohen L.G., Harlett M. Nervous system reorganisation following injury. Neuroscience 2002; 111: 761-773.
  7. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262: 689-695.
  8. Davalos A., Castillo J., Alvarez-Saben J. et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke 2002; 33: 2850-2857.
  9. Dezsi L., Kis-Varga I., Nagy J. et al. Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke [in Hungarian]. Acta Pharm Hung 2002; 72: 84-91.
  10. Durukan A., Tatlisumak T. Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacology, Biochemistry and Behavior 2007; 87; 179-197.
  11. Feigin V.L., Doronin B.M., Popova T.F. et al. Vinpocetine treatment in acute ischaemic stroke: a pilot single-blind randomized clinical trial. European J Neurology 2001; 8: 1: 81-85.
  12. Fields R., Stevens-Graham B. New insights into neuron-glia communication. Science 2002; 298: 556-562.
  13. Gaal L., Molnar P. Effect of vinpocetine on noradrenergic neurons in rat locus coeruleus. Eur J Pharmacol 1990; 187: 3: 537-539.
  14. Ginsberg M.D. Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke 2009; 40: 111-114.
  15. Hamann G.F., Okada Y., Fitridge R. et al. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke 1995; 26: 2120-2126.
  16. Harlett M. Plasticity of the human motor cortex and recovery from stroke. Brain Res Rev 2001; 36: 169-174
  17. Hayakawa M. Effect of vinpocetine on red blood cell deformabilitty in stroke patients. Arzneim-Forschung 1992; 42: 4: 425-427.
  18. Kiss B., Karpati E. Mechanism of action of vinpocetine. Acta Pharm Hung 1996; 66: 213-224.
  19. Luppino G., Rizzolatti G. The organization of the frontal motor cortex. News Physiol Sci 2000; 15: 219-224.
  20. Maletic-Savatic M., Malinow R., Svoboda K. Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity. Science 1999; 283: 1923-1927.
  21. Manchev I., Tsolova M., Mancheva V. Cavinton (vinpocetine) treatment in acute ischaemic cerebrovascular disorders [Lechenie s kavinton (vinpocetine) pri ostri ischemichni narushenia na mozhchnot krovoobrashenie]. Bulgarian Medicine 2003; 9: 4: 17-21.
  22. Miyazaki M. The effect of cerebral vasodilator, vipocetine, on cerebral vascular resistance evaluated by the Doppler ultrasonic technique in patients with cerebrovascular diseases. Angiol 1995; 46: 53-58.
  23. Nagy Z., Vargha P., Kovacs L. et al. Metaanalysis of Cavinton. Praxis 1998; 7: 63-68.
  24. Solti F., Iskum M., Czako E. Effect of ethyl apovincaminate on cerebral circulation. Studies in patients with obliterative cerebral arterial disease. Arzneim-Forschung 1976; 26: 1945-1947.
  25. Stroemer R.P., Kent T.A., Hulsebosch C.E. Neocortical Neural Sprouting, Synaptogenesis, and Behavioral Recovery After Neocortical Infarction in Rats Stroke 1995; 26: 2135-2144.
  26. Szakall Sz., Boros L., Balkay L. Cerebral effects of a single dose of intravenouse vinpocetine in chronic stroke patients: a PET study. J Neuroimagine 1998; 8: 197-204.
  27. Szilagyi G., Nagy Z., Balkay L. et al. Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study. Neurol Sci 2005; 229-230: 1: 275-284.
  28. Werner J., Apececha M., Schaltenbrand R. et al. Clinical study to evaluate the efficacy and tolerance of vinpocetine i.v. added to standard therapy in patients suffering from an acute apoplectic insult. In: Bés A., editor(s). Senile Dementias: Early Detection. John Libbey Eurotext 1986; 636-641.
  29. Xerri C. Post-lesional plasticity of somatosensory cortex maps: a review. C R Acad Sci 1998; 321: 135-151.
  30. Young A.R., Ali C., Duretete A. et al. Neuroprotection and stroke: time for a compromise. J Neurochem 2007; 103: 1302-1309.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.